TY - JOUR
T1 - No association of alcohol use and the risk of ulcerative colitis or Crohn’s disease
T2 - data from a European Prospective cohort study (EPIC)
AU - Bergmann, M. M.
AU - Hernandez, V.
AU - Bernigau, W.
AU - Boeing, H.
AU - Chan, S. S M
AU - Luben, R.
AU - Khaw, K. T.
AU - van Schaik, F.
AU - Oldenburg, B.
AU - Bueno-de-Mesquita, B.
AU - Overvad, K.
AU - Palli, D.
AU - Masala, G.
AU - Carbonnel, F.
AU - Boutron-Ruault, M. C.
AU - Olsen, A.
AU - Tjonneland, A.
AU - Kaaks, R.
AU - Katzke, V.
AU - Riboli, E.
AU - Hart, A. R.
PY - 2017/1/25
Y1 - 2017/1/25
N2 - Background/Objectives:The role of long-term alcohol consumption for the risk of developing ulcerative colitis (UC) and Crohn's disease (CD) is unclear. For the first time, to prospectively assess the role of pre-disease alcohol consumption on the risk of developing UC or CD.Subjects/Methods:Nested within the European Prospective Investigation into Cancer and Nutrition (EPIC-IBD), incident UC and CD cases and matched controls where included. At recruitment, participants completed validated food frequency and lifestyle questionnaires. Alcohol consumption was classified as either: non-use, former, light (≤0.5 and 1 drink per week), below the recommended limits (BRL) (≤1 and 2 drinks per day), moderate (≤2.5 and 5 drinks per day), or heavy use (>2.5 and >5 drinks per day) for women and men, respectively; and was expressed as consumption at enrolment and during lifetime. Conditional logistic regression was applied adjusting for smoking and education, taking light users as the reference.Results:Out of 262 451 participants in six countries, 198 UC incident cases/792 controls and 84 CD cases/336 controls were included. At enrolment, 8%/27%/32%/23%/11% UC cases and 7%/29%/40%/19%/5% CD cases were: non-users, light, BRL, moderate and heavy users, respectively. The corresponding figures for lifetime non-use, former, light, BRL, moderate and heavy use were: 3%/5%/23%/44%/19%/6% and 5%/2%/25%/44%/23%/1% for UC and CD cases, respectively. There were no associations between any categories of alcohol consumption and risk of UC or CD in the unadjusted and adjusted odds ratios.Conclusion:There was no evidence of associations between alcohol use and the odds of developing either UC or CD.
AB - Background/Objectives:The role of long-term alcohol consumption for the risk of developing ulcerative colitis (UC) and Crohn's disease (CD) is unclear. For the first time, to prospectively assess the role of pre-disease alcohol consumption on the risk of developing UC or CD.Subjects/Methods:Nested within the European Prospective Investigation into Cancer and Nutrition (EPIC-IBD), incident UC and CD cases and matched controls where included. At recruitment, participants completed validated food frequency and lifestyle questionnaires. Alcohol consumption was classified as either: non-use, former, light (≤0.5 and 1 drink per week), below the recommended limits (BRL) (≤1 and 2 drinks per day), moderate (≤2.5 and 5 drinks per day), or heavy use (>2.5 and >5 drinks per day) for women and men, respectively; and was expressed as consumption at enrolment and during lifetime. Conditional logistic regression was applied adjusting for smoking and education, taking light users as the reference.Results:Out of 262 451 participants in six countries, 198 UC incident cases/792 controls and 84 CD cases/336 controls were included. At enrolment, 8%/27%/32%/23%/11% UC cases and 7%/29%/40%/19%/5% CD cases were: non-users, light, BRL, moderate and heavy users, respectively. The corresponding figures for lifetime non-use, former, light, BRL, moderate and heavy use were: 3%/5%/23%/44%/19%/6% and 5%/2%/25%/44%/23%/1% for UC and CD cases, respectively. There were no associations between any categories of alcohol consumption and risk of UC or CD in the unadjusted and adjusted odds ratios.Conclusion:There was no evidence of associations between alcohol use and the odds of developing either UC or CD.
UR - http://www.scopus.com/inward/record.url?scp=85010871665&partnerID=8YFLogxK
U2 - 10.1038/ejcn.2016.271
DO - 10.1038/ejcn.2016.271
M3 - Article
C2 - 28120853
AN - SCOPUS:85010871665
SN - 0954-3007
VL - 71
SP - 512
EP - 518
JO - European Journal of Clinical Nutrition
JF - European Journal of Clinical Nutrition
IS - 4
ER -